An observational, cohort study to evaluate the efficacy of tocilizumab with concomitant methotrexate in patients with highly active rheumatoid arthritis.

Trial Profile

An observational, cohort study to evaluate the efficacy of tocilizumab with concomitant methotrexate in patients with highly active rheumatoid arthritis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Jul 2015

At a glance

  • Drugs Tocilizumab (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top